Blue Star Helium Secures US Offtake Deal for Pinon Canyon Output

Short-Term Helium Offtake Secures Revenue Pathway

Blue Star Helium Limited (ASX:BNL) has formalised its first helium offtake agreement, locking in a three-month contract with a major US industrial gases corporation. This agreement covers all helium produced at the Pinon Canyon Plant, the processing hub for its Galactica Project in North America. The fixed pricing mirrors the current US spot market, providing Blue Star with immediate cash flow as it negotiates longer-term deals.

Counterparty Credentials and Contract Details

The counterparty is a publicly listed US company with multibillion-dollar market capitalisation and a strong investment grade credit rating, underscoring the commercial validation of Blue Star’s helium quality and project fundamentals. While the exact identity and pricing remain confidential, the company emphasises that the counterparty’s stature does not materially affect Blue Star’s share value. The contract runs until 31 August 2026, bridging the gap between initial spot sales and the anticipated broader, longer-term helium supply agreements.

Production Progress at Pinon Canyon

Since commencing integrated operations in March 2026, Blue Star has been refining the Pinon Canyon Plant through commissioning and optimisation phases typical of new helium processing facilities. Managing Director Trent Spry recently visited the site to oversee these efforts, which have led to improved uptime and more stable production cycles. Initial helium sales have been conducted on a trailer-by-trailer spot basis, but the new agreement will enable more consistent delivery as steady-state operations take hold. This progress follows the company’s earlier milestone of tying six wells into the facility, marking Stage 1 completion of the Galactica Project and setting the stage for 24/7 production operations.

Helium Market Dynamics Support Strategic Position

The North American helium market remains robust, driven by persistent demand from semiconductor manufacturing, aerospace, and defence sectors. Supply chain disruptions, especially geopolitical instability affecting Middle Eastern sources, have tightened global helium inventories and increased the premium on reliable US-sourced helium. Blue Star’s geographically strategic asset base positions it well to benefit from these market conditions, as domestic supply becomes increasingly critical.

CO2 Commercialisation Discussions Advance

Alongside helium, Blue Star is progressing commercial negotiations for the co-produced CO2 from the Pinon Canyon Plant. Securing a market for this by-product would diversify revenue streams and enhance project economics. The company is engaged with multiple parties in advanced discussions, aiming to finalise a commercial solution soon.

CEO Comments Highlight Strategic Milestone

Trent Spry described the short-term offtake agreement as a significant commercial milestone that validates the Galactica Project and establishes Blue Star as a credible supplier in the US helium market. He noted the importance of the fixed pricing reflecting strong spot market conditions and the calibre of the counterparty as key endorsements. This transitional contract provides operational continuity while the company finalises longer-term structural agreements to underpin future growth.